| Financial Year |
March 31 2023 |
| Monetary Funds |
3,461,865,832.93 |
| Held-for-trading Financial Assets |
214,152,960.23 |
| Notes Receivable |
263,842,302.14 |
| Accounts Receivable |
1,052,331,377.88 |
| Advances to Suppliers |
2,468,719,603.25 |
| Other Receivables |
28,658,524.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,634,972,574.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
247,810,085.26 |
| Total Current Assets |
11,372,553,260.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
371,210,246.73 |
| Fixed Assetes |
4,956,247,213.12 |
| Under-construction Projects |
402,126,239.56 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
733,848,473.66 |
| R&D expenses |
-- |
| Goodwill |
168,911,273.17 |
| Long-Term Deferred and Prepaid Expenses |
23,539,798.16 |
| Deferred Income Tax Assets |
101,827,955.18 |
| Other Non-Current Assets |
61,042,006.45 |
| Sub-Total of Non-Current Assets |
6,854,651,530.66 |
| Total Assets |
18,227,204,790.78 |
| Short-Term Loans |
2,497,313,125.11 |
| Trading Financial liabilities |
316,740.00 |
| Notes Payable |
3,220,176,054.96 |
| Accounts Payable |
575,215,210.93 |
| Accounts Received In Advance |
20,588,713.80 |
| Employee Compensation Payable |
149,484,521.50 |
| Taxes Payable |
150,126,026.84 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
226,287,487.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
308,850,425.92 |
| Other Current Liabilities |
344,478,314.81 |
| Sub-Total of Current Liabilities |
7,899,153,740.34 |
| Long-term Loans |
829,408,637.57 |
| Bonds Payable |
1,859,808,913.73 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,315,816.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,920,108,594.18 |
| Total Liabilities |
10,819,262,334.52 |
| Paid-In Capital(Or Share Stock) |
1,430,318,391.00 |
| Capital Surplus |
1,913,347,456.77 |
| Surplus Reserve |
421,821,278.02 |
| LESS:Treasury Stock |
194,940,833.10 |
| Undistributed Profits |
2,684,519,209.11 |
| Minority Stockholder's Interest |
951,071,483.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,456,870,972.63 |
| Owner's Equity（Stockholder's Equity） |
7,407,942,456.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,227,204,790.78 |
